Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00842712 · COMPLETED
Trial details
- NCT number
- NCT00842712
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.